Keywords: ranolazine, marketed, innovex, cv, therapeutics, inc, signed

Ranolazine to be marketed by Innovex

Article | 13 May 1999

Print This

CV Therapeutics Inc has signed an innovative agreement with Innovexfor the US marketing and sales of CVT's ranolazine, which is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in